Identification of a novel HER3 activating mutation homologous to EGFR-L858R in lung cancer.
about
Understanding the Impact of ErbB Activating Events and Signal Transduction on Antigen Processing and Presentation: MHC Expression as a Model.Direct estrogen receptor (ER) / HER family crosstalk mediating sensitivity to lumretuzumab and pertuzumab in ER+ breast cancer.HER3 as a Therapeutic Target in Cancer.Novel association of DJ-1 with HER3 potentiates HER3 activation and signaling in cancer.Genomic alterations of ERBB receptors in cancer: clinical implications.
P2860
Identification of a novel HER3 activating mutation homologous to EGFR-L858R in lung cancer.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Identification of a novel HER3 ...... to EGFR-L858R in lung cancer.
@ast
Identification of a novel HER3 ...... to EGFR-L858R in lung cancer.
@en
type
label
Identification of a novel HER3 ...... to EGFR-L858R in lung cancer.
@ast
Identification of a novel HER3 ...... to EGFR-L858R in lung cancer.
@en
prefLabel
Identification of a novel HER3 ...... to EGFR-L858R in lung cancer.
@ast
Identification of a novel HER3 ...... to EGFR-L858R in lung cancer.
@en
P2093
P2860
P50
P356
P1433
P1476
Identification of a novel HER3 ...... s to EGFR-L858R in lung cancer
@en
P2093
Amir Noeparast
Erik Teugels
Jacques De Grève
Johan Vansteenkiste
Marleen Renard
Olivier De Wever
P2860
P304
P356
10.18632/ONCOTARGET.6585
P407
P577
2016-01-01T00:00:00Z